|
|
||||||||
Gastrointestinal Imaging |
1 From the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021 (M.J.G.) and New York Presbyterian HospitalWeill Cornell Medical College, NY (J.C.P.). Received September 10, 1998; revision requested November 3; final revision received January 12, 1999; accepted March 1. Address reprint requests to M.J.G. (e-mail: gollubm@mskcc.org).
| Abstract |
|---|
|
|
|---|
MATERIALS AND METHODS: A computer search of pathology, radiology, and cancer registry records from 1973 to 1998 revealed six patients with primary malignant melanoma of the esophagus whose radiographs were available for review. Six esophagograms, three contrast materialenhanced chest computed tomographic (CT) scans, and four chest radiographs were reviewed. Medical records were reviewed for presenting symptoms and clinical course.
RESULTS: Six patients (age range, 6378 years; mean age, 70 years) had histopathologically proved primary malignant melanoma of the esophagus. All patients presented with dysphagia or odynophagia of 6 weeks duration or less. Esophagography and chest CT showed polypoid, nonobstructing esophageal masses, which were mucosal (n = 5) or submucosal (n = 1) and which were located in the middle (n = 3), distal (n = 2), or proximal (n = 1) third of the esophagus. Five patients underwent esophagogastrectomy: Three died a mean of 5 months afterward, two were lost to follow-up, and one was alive 7 months later.
CONCLUSION: Primary melanoma of the esophagus is rare. It is usually polypoid, intraluminal, and nonobstructive. As with other esophageal malignancies, the prognosis is dismal despite resection.
Index terms: Esophagus, neoplasms, 71.329 Melanoma, 71.329 Thorax, CT, 71.12112
| Introduction |
|---|
|
|
|---|
| MATERIALS AND METHODS |
|---|
|
|
|---|
Chest radiographs were evaluated for mediastinal or hilar masses or widening and for parenchymal masses or infiltrates. Barium esophagograms were evaluated for the size and configuration of any mass, for the presence of ulceration or obstruction, and for the appearance of the mass (infiltrative, polypoid or annular, mucosal, or mural or extramural). Contrast-enhanced CT scans were evaluated for the appearance of the primary esophageal lesion, if seen, and its size, extent (intraluminal, invasive into the mediastinum, or multifocal), and location (upper, middle, or lower third of the esophagus). CT scans were also evaluated for the presence of obstruction and for associated wall thickening. Nodal and distant organ metastatic diseases (eg, liver or lung metastases) were also evaluated. Medical records were reviewed for presenting symptoms and clinical course, including findings at histopathologic examination. All patients underwent endoscopy with biopsy. Five patients underwent esophagogastrectomy; two patients were lost to follow-up.
| RESULTS |
|---|
|
|
|---|
Five patients underwent esophagogastrectomy. Two patients were lost to long-term follow-up; one patient underwent removal of a node-negative T2 (involvement of the muscularis propria) tumor with no metastases, and the other was referred for laser ablation. The four remaining patients underwent surgical excision; three died at a mean of 5 months after surgery (range, 112 months), and one was alive at 7 months. The causes of death were myocardial infarction (n = 2) and gastrointestinal bleeding with recurrent primary and disseminated tumor (n = 1). Metastases were present in three patients and involved the liver (n = 1); axillary lymph node (n = 1, the patient lost to follow-up); and cervical and mediastinal lymph node, pulmonary, and esophagogastric anastomosis (n = 1). Results are given in the Table.
|
|
|
|
|
Findings on chest CT scans.Three patients had polypoid intraluminal masses that ranged 3.26.3 cm in length (mean, 4.8 cm) and 2.54.0 cm in maximal diameter (mean, 3.3 cm) (Fig 3). A rim of air or orally administered contrast material surrounded all lesions (Fig 3). No wall thickening or extension of the mass into adjacent mediastinal structures was appreciated. Mediastinal lymphadenopathy was absent in all three patients. A 3-cm mass in the left lower lung was present in one patient (later confirmed to be squamous cell cancer of the lung), and a 3-cm right axillary lymph node was present in another patient (later confirmed to be metastatic melanoma).
|
Histopathologic Findings
Findings at endoscopic biopsy were positive for malignancy in all patients. However, in one patient, epidermoid cancer was suspected, and in another patient, the histologic findings were not specified. Both cases were proved to be melanoma at surgery.
In five patients, the specimens obtained at esophagogastrectomy revealed four polypoid and one sessile mass (Fig 4). The mean maximal tumor diameter was 3.6 cm (range, 2.24.5 cm). Four lesions were T2 and one was T1 (limited to the submucosa). The lesion was described at esophagography as submucosal; it "deeply infiltrated the muscular wall." Four tumors were brown-black, or hemorrhagic, and one was white. In situ melanoma, lateral junctional change, or melanosis was described in three patients, and positive findings at immunohistochemical staining with HMB-45 and S-100 were described in three patients. Mediastinal lymph nodes were positive in only one of five patients.
|
| DISCUSSION |
|---|
|
|
|---|
Cutaneous melanoma frequently metastasizes to the gastrointestinal tract and has been found in 48% of patients who die of malignant melanoma (5). It most commonly spreads to the small intestine; less often, it spreads to the stomach and colon (6). Metastasis to the esophagus is rare. It reportedly occurs in only 4% (five of 125) of patients who die of metastatic melanoma and who are examined at autopsy (7).
It was originally thought that primary melanoma could not develop in the esophagus (because of the lack of precursor cells), until 1963 when De La Pava et al (8) demonstrated typical melanocytes in the esophageal mucosa in 4% of deceased patients at autopsy. This was later confirmed in the series by Tateishi et al (9), in which an incidence of 8% was found; this established the origin of primary esophageal melanoma.
The most common presenting symptoms are dysphagia (73%), weight loss (72%), pain (44%), and melena (10%) (4). Physical signs other than weight loss are uncommon. It is interesting that palpable supraclavicular lymph nodes were found in patients in two series (4,10).
Barium esophagography usually reveals a polypoid mass in the middle or distal third of the esophagus, a finding that was present in five of our patients. A considerable degree of obstruction is uncommon. A less common appearance may include that of a stricturing, circumferential mass. Other polypoid tumors of the esophagus include spindle cell carcinoma (carcinosarcoma), leiomyosarcoma, and, rarely, adenocarcinoma. Spindle cell carcinoma, a bulky polypoid intraluminal lesion that rarely causes obstruction, would be virtually indistinguishable from melanoma at radiographic examination. Benign polypoid filling defects include leiomyoma, squamous papilloma, fibrovascular polyp, and impacted food bolus (3). Squamous cell carcinoma is not commonly polypoid.
CT of the thorax may reveal a bulky esophageal mass, with compression of adjacent mediastinal structures. As with other esophageal malignancies, CT may be most useful in demonstrating mediastinal invasion, nodal enlargement, and distant metastatic disease. Melanoma usually involves the local-regional nodes, lung and/or pleura, and liver.
At endoscopy, lesions may appear as polypoid, intraluminal, darkly colored or nonpigmented masses with intact mucosa or occasional ulceration (2). Specimens obtained at endoscopic biopsy reveal limited data for a definitive diagnosis. Findings are often mistakenly interpreted as revealing poorly differentiated squamous cell cancer. This occurred in two of our patients. Confirmation of findings at histologic examination is usually made after en bloc resection (11).
Gross specimens are polypoid, variably sized, and pigmented in 85% of patients. Ulcerations may be present, but more often the tumor is covered with intact mucosa. In one series, "satellite" tumor nodules were present in 12% of patients and, at times, were distant from the tumor (10).
At the microscopic level, this tumor involves the mucosa and submucosa and grows in a lentiginous (nodular infiltrative), radial manner. The overlying squamous mucosa is usually intact. Lymphatic and vascular invasion is common. Electron microscopy demonstrates premelanosomes. Immunohistochemical results are positive with HMB-45 or S-100 staining but are negative for cytokeratin staining.
Melanoma of the esophagus can be considered primary when it has the characteristic structure of melanoma, when it contains pigment that is demonstrable as melanin with the appropriate staining technique, and when the adjacent epithelium has melanocytic proliferation and shows junctional change. Other sites of primary melanoma must be excluded (2,10).
The treatment of choice for primary melanoma of the esophagus is surgical resection en bloc, with dissection of the lymph nodes. Because of the potential for "satellite" mucosal tumor nodules, the surgical procedure should include a radical resection with a greater margin than that used for the usual squamous cell carcinoma. The propensity for submucosal spread may lead to incomplete excision (10). Adjuvant or neoadjuvant radiation therapy has been used, but its utility is unproved (4). Currently, it is believed that chemotherapy and immunotherapy have no major role in treatment (2).
The prognosis for patients with this tumor is dismal. Metastases are present at the time of diagnosis in 49% of cases (11). Despite curative or palliative surgical resection, patients with this aggressive malignancy usually present late in the course of disease and progress to early death, with widespread metastases. As a result, the 5-year survival rate ranges from 0% to 4% (median survival, 57 months) (4,6). At our institution, in a previously reported series, seven of eight primary esophageal melanomas were resected. Three patients received chemotherapy. The 3- and 5-year survival rates were 13% (one of eight patients) and 0%, respectively (median survival, 4.7 months) (4).
In summary, primary melanoma of the esophagus is a rare, aggressive malignancy that should be considered in the differential diagnosis of polypoid esophageal masses on esophagograms and chest CT scans. The appearance is more likely to be caused by spindle cell carcinoma or leiomyosarcoma. However, it is important to obtain a preoperative diagnosis at histologic examination, since more aggressive surgery may be needed to properly treat these patients.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
G B Fogarty, C J Tartaglia, and L J Peters Primary melanoma of the oesophagus well palliated by radiotherapy Br. J. Radiol., December 1, 2004; 77(924): 1050 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Dachman, P. Schumm, B. Heckel, H. Yoshida, and P. LaRiviere The Effect of Reconstruction Algorithm on Conspicuity of Polyps in CT Colonography Am. J. Roentgenol., November 1, 2004; 183(5): 1349 - 1353. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Kim, H. K. Ha, A. Y. Kim, T. K. Kim, J.-S. Kim, C. S. Yu, S. W. Park, M.-S. Park, H. J. Kim, P.-N. Kim, et al. Primary Malignant Melanoma of the Rectum: CT Findings in Eight Patients Radiology, July 1, 2004; 232(1): 181 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.M. Klaase, J.B. F. Hulscher, G.J. A. Offerhaus, F.J. W. ten Kate, H. Obertop, and J.J. B. van Lanschot Surgery for Unusual Histopathologic Variants of Esophageal Neoplasms: A Report of 23 Cases With Emphasis on Histopathologic Characteristics Ann. Surg. Oncol., April 1, 2003; 10(3): 261 - 267. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |